Publications
193
Citations
13,930
Est. group size
~2
Recurring co-author estimate
Active years
39
Publishing since 1988
Andrea G. Hohmann studies how the body's own cannabis-like chemical system (the endocannabinoid system) and related receptors can be used to treat pain, especially the nerve pain caused by chemotherapy. The research combines animal studies, pharmacology, and drug design to find safer treatments for chronic pain and to understand the effects of drugs like opioids, fentanyl, and xylazine on breathing and reward.
Publication activity has been sustained across the decade with year-to-year fluctuation, and has been relatively high in the most recent years (16 in 2025).
Generated by claude-opus-4-8 from public bibliographic data · Jul 9, 2026
Current awards run through June 2030 — about 4 years of funding on record from today. Awards are often renewed, so this is what is currently public, not a forecast.
INTEGRATIVE PREDOCTORAL TRAINING IN DRUG ABUSE RESEARCH AT INDIANA UNIVERSITY
7 earlier awards
- NIH R01DA047858Apr 2019 – Feb 2026 · $517k awarded
CB2 Cannabinoid Mechanisms for Suppressing Opioid Tolerance and Dependence
- NIH R01DA041229Apr 2016 – Jan 2022 · $351k awarded
Role of CB2 in Analgesic Mechanisms
- NIH R01CA200417Jan 2016 – Dec 2021 · $283k awarded
NOS1AP as a novel target for treating pathological pain
- NIH R21DA042584Aug 2016 – Jul 2020 · $197k awarded
A Novel Mechanism for Decreasing Opioid Reward
- NIH R21DA037673Sep 2013 – Aug 2016 · $234k awarded
Protein-protein interaction inhibitors as novel analgesics
- NIH R01DA021644Aug 2006 – May 2013 · $498k awarded
AN ENDOCANNABINOID MECHANISM FOR STRESS-INDUCED ANALGESIA
- NIH RC1DA028200Sep 2009 – Aug 2012 · $396k awarded
An Animal Model of Therapeutic Self-Medication for Neuropathic Pain
Matched to public NIH RePORTER and NSF records by name and institution. Awards from other agencies are not shown, and a match is not always found — this list may be incomplete.
Typically publishes in teams of ~7 · 7% small-team papers (≤3 authors) · across 48 venues
- Cannabidiol attenuates chemotherapy-induced peripheral neuropathic pain through a mechanism that requires the enzyme N-acylphosphatidylehtanolamine-specific phospoholipase D (NAPE-PLD)
Zenodo (CERN European Organization for Nuclear Research) · 2026
- Cannabidiol attenuates chemotherapy-induced peripheral neuropathic pain through a mechanism that requires the enzyme N -acylphosphatidylethanolamine-specific phospholipase D (NAPE-PLD)
bioRxiv (Cold Spring Harbor Laboratory) · 2026
- Xylazine exacerbates fentanyl-induced respiratory depression and prevents rescue by naloxone in mice
Psychopharmacology · 2026
- Targeting Conformational Flexibility of a Reactive Intermediate to Enhance Selectivity of a GABA Aminotransferase Inactivator
Journal of the American Chemical Society · 2026
- Xylazine exacerbates fentanyl-induced respiratory depression and prevents rescue by naloxone in mice
Zenodo (CERN European Organization for Nuclear Research) · 2026
- Xylazine exacerbates fentanyl-induced respiratory depression and prevents rescue by naloxone in mice
Zenodo (CERN European Organization for Nuclear Research) · 2026
- Assessments of Evoked and Spontaneous Pain Following Administration of Gabapentin and the Cannabinoid CB 2 Agonist LY2828360 in a Rat Model of Spared Nerve Injury
Cannabis and Cannabinoid Research · 2026
- Cannabinoid CB 1 allosteric ligands suppress inflammatory pain in male mice without tolerance, motor impairment, memory deficits or respiratory depression
British Journal of Pharmacology · 2026
- MILD TRAUMATIC BRAIN INJURY IMPAIRS EPISODIC MEMORY IN RATS
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Acetaminophen alters endogenous lipid signaling and attenuates pathological pain through a mechanism requiring diacylglycerol lipase, monoacylglycerol lipase and cannabinoid CB1 receptors in mice
bioRxiv (Cold Spring Harbor Laboratory) · 2025
- Multiple mechanisms of action for an extremely painful venom
Current Biology · 2025
- Exceptionally Potent Chiral Anandamide Analogs
Journal of Medicinal Chemistry · 2025
- CB1 cannabinoid receptor agonists induce acute respiratory depression in awake mice
Pharmacological Research · 2025
- Cannabinoid CB2 receptor‐mediated analgesia: mechanism‐based insights and therapeutic potential
British Journal of Pharmacology · 2025
- Mice lacking the endocannabinoid-synthesizing enzyme NAPE-PLD exhibit sex-dependent dysregulations in responsiveness to oxycodone and a natural reward
Neuropharmacology · 2025
- bioRxiv (Cold Spring Harbor Laboratory)×17
- Neuropharmacology×7
- Pain×5
- Pharmacological Research×5
- Journal of Medicinal Chemistry×4
- Kelsey G. Guenther
Medicine · Indiana University
- Vishakh Iyer
Medicine · Indiana University
- Xiaoyan Lin
Medicine · Indiana University
- Michaela Dvořáková
Medicine · Indiana University
- Jim Wager‐Miller
Medicine · Indiana University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Sep 1, 2026.
Claim or correct this profile